申请人:Gilead Sciences, Inc.
公开号:US10604490B2
公开(公告)日:2020-03-31
The present disclosure provides processes for the preparation of a compound of formula:
which exhibits apoptosis signal-regulating kinase (“ASK1”) inhibitory activity and is thus useful in the treatment of diseases such as kidney disease, diabetic nephropathy and kidney fibrosis. The disclosure also provides compounds that are synthetic intermediates.
本公开提供了制备式化合物的工艺:
该化合物具有抑制细胞凋亡信号调节激酶("ASK1")的活性,因此可用于治疗肾脏疾病、糖尿病肾病和肾脏纤维化等疾病。本公开还提供了作为合成中间体的化合物。